Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elodie Rabut"'
Autor:
Nadine Ajzenberg, Elodie Rabut, Nicolas Schleinitz, Annabelle Dupont, Thomas Papo, Dorothée Faille, Tiphaine Goulenok, Emmanuelle de Raucourt, Chloé James, Karim Sacre, Corinne Frere, Claire Vasco, Lucia Rugeri
Publikováno v:
British Journal of Haematology. 192:892-899
Acquired factor V inhibitor (AFVI) is an extremely rare disorder that may cause severe bleeding. To identify factors associated with bleeding risk in AFVI patients, a national, multicentre, retrospective study was made including all AFVI patients fol
Case report: serological testing interference of daratumumab (anti-CD38) therapy in multiple myeloma
Publikováno v:
Annales de biologie clinique. 75:351-355
We report the case of a 54 years old patient monitored for a monoclonal IgG kappa light chain refractory relapsed multiple myeloma and receiving daratumumab immunotherapy. Daratumumab (DARA), a monoclonal anti-CD38 antibody, belongs to the new genera
Publikováno v:
Transfusion Clinique et Biologique. 24:341-342
Objectif Evaluer un kit de detection et quantification de l’hemorragie fœto-maternelle par cytometrie en flux utilisant un double marquage antihemoglobine fœtale (anti-HbF) et anti-anhydrase carbonique (anti-AC). Materiel & methode Vingt-neuf pre
Autor:
Elodie Rabut, Jean-Philippe Jais, Jonathan Pol, Catherine Osada, Jean Claude Nicolas, Fadila Zatla, Patrick Soussan, Agnes Beby-Defaux, Marilyse Pilloux, Hichem Assami, Jean Didier Grange, Dina Kremsdorf, Catherine Le Pendeven
Publikováno v:
Journal of Virological Methods
Journal of Virological Methods, 2008, 154 (1-2), pp.1-6. ⟨10.1016/j.jviromet.2008.09.014⟩
Journal of Virological Methods, Elsevier, 2008, 154 (1-2), pp.1-6. ⟨10.1016/j.jviromet.2008.09.014⟩
Journal of Virological Methods, 2008, 154 (1-2), pp.1-6. ⟨10.1016/j.jviromet.2008.09.014⟩
Journal of Virological Methods, Elsevier, 2008, 154 (1-2), pp.1-6. ⟨10.1016/j.jviromet.2008.09.014⟩
International audience; The quantitation of human hepatitis B virus (HBV) in the serum of infected patients is recommended to characterize the course of chronic HBV infection. The aim of this prospective study was to evaluate the performance of the A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52538acf5a7163d28f31fcdab44ac408
https://www.hal.inserm.fr/inserm-02454920/document
https://www.hal.inserm.fr/inserm-02454920/document